Annual EBIT
-$166.24 M
+$43.44 M+20.72%
31 December 2023
Summary:
Centessa Pharmaceuticals annual earnings before interest & taxes is currently -$166.24 million, with the most recent change of +$43.44 million (+20.72%) on 31 December 2023. During the last 3 years, it has fallen by -$155.95 million (-1516.29%). CNTA annual EBIT is now -3263.04% below its all-time high of -$4.94 million.CNTA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$39.40 M
+$1.19 M+2.92%
30 September 2024
Summary:
Centessa Pharmaceuticals quarterly earnings before interest & taxes is currently -$39.40 million, with the most recent change of +$1.19 million (+2.92%) on 30 September 2024. Over the past year, it has dropped by -$468.00 thousand (-1.20%). CNTA quarterly EBIT is now -236.24% below its all-time high of $28.92 million, reached on 01 December 2020.CNTA Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$148.15 M
-$468.00 K-0.32%
30 September 2024
Summary:
Centessa Pharmaceuticals TTM earnings before interest & taxes is currently -$148.15 million, with the most recent change of -$468.00 thousand (-0.32%) on 30 September 2024. Over the past year, it has increased by +$26.60 million (+15.22%). CNTA TTM EBIT is now -391.92% below its all-time high of $50.75 million, reached on 31 March 2021.CNTA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNTA EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +20.7% | -1.2% | +15.2% |
| 3 y3 years | -1516.3% | +1.9% | -380.1% |
| 5 y5 years | - | - | - |
CNTA EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -1516.3% | +20.7% | -18.9% | +37.5% | -380.1% | +29.4% |
| 5 y | 5 years | -3263.0% | +20.7% | -236.2% | +37.5% | -391.9% | +29.4% |
| alltime | all time | -3263.0% | +20.7% | -236.2% | +37.5% | -391.9% | +29.4% |
Centessa Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$39.40 M(-2.9%) | -$148.15 M(+0.3%) |
| June 2024 | - | -$40.59 M(+15.8%) | -$147.68 M(-3.8%) |
| Mar 2024 | - | -$35.04 M(+5.8%) | -$153.58 M(-7.6%) |
| Dec 2023 | -$166.24 M(-20.7%) | -$33.12 M(-14.9%) | -$166.24 M(-4.9%) |
| Sept 2023 | - | -$38.93 M(-16.2%) | -$174.75 M(-7.0%) |
| June 2023 | - | -$46.49 M(-2.5%) | -$187.91 M(-8.1%) |
| Mar 2023 | - | -$47.69 M(+14.6%) | -$204.45 M(-2.5%) |
| Dec 2022 | -$209.68 M | -$41.63 M(-20.1%) | -$209.68 M(+24.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$52.09 M(-17.4%) | -$168.04 M(+7.6%) |
| June 2022 | - | -$63.03 M(+19.1%) | -$156.10 M(+16.0%) |
| Mar 2022 | - | -$52.92 M(+31.8%) | -$134.52 M(+336.0%) |
| Sept 2021 | - | -$40.16 M(-3.1%) | -$30.86 M(-431.9%) |
| June 2021 | - | -$41.45 M(-289.9%) | $9.30 M(-81.7%) |
| Mar 2021 | - | $21.83 M(-24.5%) | $50.75 M(+75.5%) |
| Dec 2020 | -$10.29 M(+108.1%) | - | - |
| Dec 2020 | - | $28.92 M | $28.92 M |
| Dec 2019 | -$4.94 M | - | - |
FAQ
- What is Centessa Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Centessa Pharmaceuticals?
- What is Centessa Pharmaceuticals annual EBIT year-on-year change?
- What is Centessa Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Centessa Pharmaceuticals?
- What is Centessa Pharmaceuticals quarterly EBIT year-on-year change?
- What is Centessa Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Centessa Pharmaceuticals?
- What is Centessa Pharmaceuticals TTM EBIT year-on-year change?
What is Centessa Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of CNTA is -$166.24 M
What is the all time high annual EBIT for Centessa Pharmaceuticals?
Centessa Pharmaceuticals all-time high annual earnings before interest & taxes is -$4.94 M
What is Centessa Pharmaceuticals annual EBIT year-on-year change?
Over the past year, CNTA annual earnings before interest & taxes has changed by +$43.44 M (+20.72%)
What is Centessa Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of CNTA is -$39.40 M
What is the all time high quarterly EBIT for Centessa Pharmaceuticals?
Centessa Pharmaceuticals all-time high quarterly earnings before interest & taxes is $28.92 M
What is Centessa Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, CNTA quarterly earnings before interest & taxes has changed by -$468.00 K (-1.20%)
What is Centessa Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of CNTA is -$148.15 M
What is the all time high TTM EBIT for Centessa Pharmaceuticals?
Centessa Pharmaceuticals all-time high TTM earnings before interest & taxes is $50.75 M
What is Centessa Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, CNTA TTM earnings before interest & taxes has changed by +$26.60 M (+15.22%)